Whittier Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61K Buy
108
+3
+3% +$1.39K ﹤0.01% 841
2026
Q1
$52.1K Hold
105
﹤0.01% 831
2025
Q4
$63.9K Hold
105
﹤0.01% 820
2025
Q3
$55.9K Hold
105
﹤0.01% 829
2025
Q2
$33K Sell
105
-4
-4% -$1.2K ﹤0.01% 1027
2025
Q1
$33.2K Buy
109
+35
+47% +$11.8K ﹤0.01% 1011
2024
Q4
$24.6K Buy
74
+17
+30% +$5.76K ﹤0.01% 1060
2024
Q3
$19K Hold
57
﹤0.01% 1121
2024
Q2
$23.5K Buy
57
+7
+14% +$2.77K ﹤0.01% 1060
2024
Q1
$20.2K Hold
50
﹤0.01% 1123
2023
Q4
$15.3K Sell
50
-48
-49% -$13K ﹤0.01% 1156
2023
Q3
$23.7K Hold
98
﹤0.01% 1082
2023
Q2
$23.5K Hold
98
﹤0.01% 1087
2023
Q1
$18.4K Buy
98
+53
+118% +$11K ﹤0.01% 1172
2022
Q4
$9.56K Buy
+45
New +$8.99K ﹤0.01% 1300

Other funds holding MEDP

Whittier Trust's MEDP Position: Q2 2026 in Review

Whittier Trust increased its Medpace (MEDP) stake by 2.9% in Q2 2026, buying an estimated $1.39K and bringing the position to 108 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Whittier Trust first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $63.9K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Whittier Trust held 108 shares of Medpace worth $61K as of Q2 2026.
  • Whittier Trust bought 3 Medpace shares in Q2 2026, an estimated $1.39K.
  • Medpace made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #841 holding.
  • Whittier Trust first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Whittier Trust's Medpace position peaked at $63.9K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.